Long-Term Evaluation of TAILORED Vs Anatomical Ablation Strategy for Persistent Atrial Fibrillation

Last updated: March 10, 2025
Sponsor: Volta Medical
Overall Status: Active - Recruiting

Phase

N/A

Condition

Chest Pain

Atrial Fibrillation

Dysrhythmia

Treatment

Volta AF-Xplorer

Dispersion ablation + PVI

PVI

Clinical Study ID

NCT06825104
CLIPL-01-006
  • Ages > 18
  • All Genders

Study Summary

The TAILORED-LT study is conducted as an extension follow-up until 5 years of the initial TAILORED-AF study (NCT04702451), in order to demonstrate the long-term superiority in terms of freedom of atrial fibrillation (AF) of a tailored ablation strategy targeting areas of spatio-temporal dispersed electrograms in combination with pulmonary veins isolation (PVI) over an anatomical ablation strategy targeting PVI alone for the initial ablation procedure of persistent AF.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Patient who participated in the Tailored AF study

  • Patient not withdrawn during the 12-month follow-up period post-index procedure inthe Tailored AF study

  • Patient able and willing to provide written informed consent to participate in thisextension Tailored-LT study

Exclusion

Exclusion Criteria:

  • Person deprived of liberty or under guardianship

  • Person unable to undergo a medical monitoring for geographical, social orpsychological reasons

Study Design

Total Participants: 278
Treatment Group(s): 3
Primary Treatment: Volta AF-Xplorer
Phase:
Study Start date:
March 06, 2025
Estimated Completion Date:
December 31, 2027

Study Description

The TAILORED-AF study demonstrated at one year's follow-up that a tailored ablation strategy guided by Volta Medical AI-software targeting areas of spatio-temporal dispersed electrograms in combination with pulmonary vein isolation (PVI) ablation is more effective to an anatomical ablation strategy targeting PVI alone (current standard of care) for the treatment of persistent atrial fibrillation (AF).

VX1 legacy device renamed Volta AF-Xplorer was used in the TAILORED-AF study in the treatment arm.

No additional treatments are specifically required in the scope of this ancillary TAILORED-LT study which aims to follow the patients previously treated in the initial TAILORED-AF study over the long-term. However, in the event of repeat procedures during the TAILORED-LT study, the choice of the ablation technique will be left to the investigator's discretion, regardless of the patient's randomization arm in the TAILORED-AF study.

The annual follow-up will be performed as in routine clinical practice post AF ablation procedures: visits at 24 months, 36 months, 48 months and 60 months post TAILORED-AF Study index procedure. It is possible that some of these annual visits cannot be completed prospectively due to time already having elapsed between the end of the subject participation in the TAILORED-AF study and the date of enrollment in the extension TAILORED-LT study. In this case, available data (among those expected by the study protocol) will be collected retrospectively.

The additional procedures related to this clinical investigation are limited to annual 24-hour Holters and to the administration of Quality Of Life questionnaires (SF-36 and AFEQT) to the patients during follow-up visits.

Connect with a study center

  • CHU Lyon, Hôpital Louis Pradel

    Bron, 69677
    France

    Site Not Available

  • Pôle Santé République

    Clermont-Ferrand, 63050
    France

    Site Not Available

  • Hôpital Saint Philibert

    Lomme, 59462
    France

    Site Not Available

  • Hôpital Saint-Joseph Marseille

    Marseille, 13008
    France

    Active - Recruiting

  • Hôpital Privé Jacques Cartier

    Massy, 91300
    France

    Site Not Available

  • Hôpital Privé du Confluent

    Nantes, 44277
    France

    Site Not Available

  • Polyclinique Saint George

    Nice, 06105
    France

    Site Not Available

  • Centre Cardiologique du Nord

    Saint-Denis, 93207
    France

    Site Not Available

  • Clinique Rhéna

    Strasbourg, 67000
    France

    Site Not Available

  • Clinique Pasteur

    Toulouse, 31076
    France

    Site Not Available

  • CHRU Nancy, Institut Lorrain du coeur et des vaisseaux

    Vandœuvre-lès-Nancy, 54500
    France

    Site Not Available

  • Klinikum Coburg

    Coburg, 96450
    Germany

    Site Not Available

  • German Heart Center

    Munich, 80636
    Germany

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.